We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

A minor fibrillation

22 May 2007 By Una Galani

The UK pharmaceuticals shares have taken a battering after a study linked its blockbuster diabetes drugs to higher risk of heart attacks. The author is credible, but his technique is disputed. For now, it looks like Glaxo will only suffer mild damage.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)